OOIR: Observatory of International Research

Papers

(The median citation count of Clinical & Translational Immunology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
	46
	44
SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system	30
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis	28
Characteristics of PD‐1⁺CD4⁺ T cells in peripheral blood and synovium of rheumatoid arthritis patients	26
Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant	25
An optimised whole blood interleukin‐2 release assay is more sensitive than interferon‐γ ELIS pot for detecting and quantifying gluten‐specific	24
Spatial omics for profiling the dynamic tumor microenvironment	24
The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4‐related disease	21
Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation	20
	17
Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID‐19	17
High IL ‐10 levels during CRS are negatively associated with NK	17
	15
	15
Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma	14
Targeting BMI‐1 to deplete antibody‐secreting cells in autoimmunity	14
Adeno‐associated viral vectors encoding anti‐P2X7 nanobodies reduce graft‐versus‐host disease in a humanised mouse model	14
Effects of extremely preterm birth on cytokine and chemokine responses induced by T‐cell activation during infancy	13
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease	13
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation	13
Inhibitory effect of hydroxychloroquine on glucocorticoid‐induced osteoporosis in lupus therapy	12
	12
Optimised modular anti‐FLAG CAR T cells for solid tumor therapy	12
Genome‐wide association study and polygenic risk scores of eosinophilia in Taiwan	12

Siglec‐1, an easy and contributory inflammation marker in rheumatology	11
Immunological insights into gastric polyps: pathogenesis, inflammation and neoplastic potential	11
	10
High KRT17 expression in tumour budding indicates immunologically ‘hot’ tumour budding and predicts good survival in patients with colorectal cancer	10
Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models	10
	10
Naturally acquired adaptive immunity to Streptococcus pneumoniae is impaired in rheumatoid arthritis patients	10
	10
Alterations of circulating innate lymphoid cells in recent‐onset type 1 diabetes	10
Adaptive immune response to the autoantigen LL ‐37 differentiates atherosclerotic cardiovascular disease phenotypes	10
Human axillary lymph node T follicular helper (Tfh) and Precursor‐Tfh cells exhibit functional flexibility following seasonal influenza vaccination	9
Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity	9
Fatty acid metabolism—an emerging regulatory node in T‐cell immunometabolism	9
	9
Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis	9
Skin immunity and inflammation: cellular interactions and communication	9
	8
Data standards for single‐cell RNA‐sequencing of paediatric cancer	8
Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort	8
	8
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies	8
A novel case of autosomal recessive CARD11 loss‐of‐function underlying impaired antiviral immunity and a review of literature	7
Neutralising antibody responses to emerging SARS ‐ CoV ‐2 omicron sub‐variants are enhanced in per	7
CD39 expression defines exhausted CD4⁺ T cells associated with poor survival and immune evasion in human gastric cancer	7
	7
Pulmonary complications post allogeneic haematopoietic stem cell transplant in children	7
Helminths as architects of trained tolerance: implications for human health	7
The impact of B‐cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients	7
Hypoxia‐inducible factor‐1α regulates the interleukin‐6 production by B cells in rheumatoid arthritis	7
A comprehensive analysis of the correlation between plasma cytokines/chemokines and tumor immune microenvironment signature influences the response of checkpoint inhibitors in advanced non‐small‐cell	6
Long‐term effects of influenza and Bacille Calmette–Guérin vaccination on systemic inflammation	6
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis	6
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients	6
Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis	6
Spatial proteomic profiling of tumor and stromal compartments in non‐small‐cell lung cancer identifies signatures associated with overall survival	6
	6
A unique cytotoxic CD4 ⁺ T cell‐signature defines critical COVID‐19	6
Multi‐omics integration reveals a nonlinear signature that precedes progression of lung fibrosis	6
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis	6
Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation	5
High‐dimensional spectral cytometry identifies follicular regulatory CD8 ⁺ T cells in diffuse large B‐cell lymphoma	5
Antigen‐specific polyfunctional cytotoxic T cells differentiate intraocular from peripheral blood immune responses in posterior uveitis	5
Elucidating novel immune profiles for predicting infection in high‐risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia	5
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination	5
Glucocorticoid regulation of the mTORC1 pathway modulates CD4⁺ T cell responses during infection	5
	5
Genetic differences in the HLA region contribute to the variability in SARS‐CoV‐2 vaccine responsiveness of older persons: the Doetinchem Cohort Study	5
Elevated high‐density lipoprotein levels following acute graft‐versus‐host disease onset: a potential link to T‐cell dysfunction and increased relapse risk	5
CD8⁺ T cell epitope conservation in emerging H5N1 viruses suggests global protection	4
Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience apply	4

A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases	4
	4
	4
A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors	4
Clinical, biological and cytometric characteristics of two patients with a homozygous A91V PRF1 mutation	4
	4
Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune‐driven demyelination	4
	4
Integrating mass spectrometry‐based multi‐omic signatures of extracellular vesicles: from discovery to clinical translation	4
Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection	3
Improving thymus implantation for congenital athymia with interleukin‐7	3
	3
	3
SARS‐CoV‐2‐infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses	3
	3
Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma	3
Roadmap for understanding mechanisms on how Epstein–Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials	3
	3
Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism	3
Epstein–Barr virus and multiple sclerosis: the dawn of a new age	3
Prolonged persistence of tissue‐resident memory cells in the upper airway following SARS ‐ CoV ‐2	3
	3
From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL‐33	3
γδ T cell characterisation in the long term after haematopoietic stem cell transplantation and its impact on CMV control and cGVHD severity	3
Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non‐infectious uveitis	3
Integrated humoral and inflammatory signatures predict outcomes in severe COVID ‐19: a 14‐day longitudinal analysis	3
	3
Engineered iPSC ‐derived natural killer cells: recent innovations in translational innate anti‐cancer immunotherapy	3
	3
Enhancing CAR T‐cell therapy manufacturing efficiency through semi‐automated bioprocessing	3
The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic region	3
Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan‐cancer analysis	3
Serum AZD7442 (tixagevimab–cilgavimab) concentrations and in vitroIC₅₀ values predict SARS‐CoV‐2 neutralising antibody titres	2
Data standards for single‐cell RNA‐sequencing of paediatric cancer	2
Long‐lasting changes in circulating dendritic cell and monocyte subsets, and altered expression of EMR2, CD97 and EMR3 on these cells in the posttraumatic course	2
Whole transcriptome profiling of placental pathobiology in SARS‐CoV‐2 pregnancies identifies placental dysfunction signatures	2
Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1‐RUNX1T1	2
Chimeric antigen receptor T cells in the fast lane among autoimmune disease therapies	2
	2
Coexistence of SAPHO syndrome and IgG4‐related disease with Upadacitinib	2
Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis	2
Single‐cell and repertoire profiling reveals immune remodelling in paediatric upper airway: insights from adenoid hypertrophy	2
An Ad26‐ MVA ‐ BN ‐based therapeutic vaccine targeting HPV16	2
Aberrant intra‐epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103 ‐β7‐receptor‐mediated granzyme‐B degranulatio	2
Low‐level human memory T and B cells recognising avian influenza hemagglutinins are poorly responsive to existing seasonal influenza vaccines	2
Plasma SARS‐CoV‐2 RNA elimination and RAGE kinetics distinguish COVID‐19 severity	2
Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells	2
	2
Gut metabolites identified in cerebrospinal fluid of genetic interferonopathy support gut–brain endothelial dysfunction	2
Elevated BMI reduces the humoral response to SARS‐CoV‐2 infection	2
Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis	2